Production of cells with targeted integration of gene variants of human ABC transporter for stable and regulated expression using the Flp recombinase system

Methods in Molecular Biology

Volumn 648, Issue , 2010, Pages 139-159

  Wakabayashi Nakao, Kanako ^a   Tamura, Ai ^a   Koshiba, Shoko ^a   Toyoda, Yu ^a   Nakagawa, Hiroshi ^a   Ishikawa, Toshihisa ^a  

^a NONE

Author keywords

Aggresome; ATP binding cassette (ABC) transporter; Endoplasmic reticulum associated degradation (ERAD); Flp recombinase; Genetic polymorphisms; N linked glycosylation; Proteasome

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; COMPLEMENTARY DNA; GENOMIC DNA; RECOMBINASE; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; DNA POLYMERASE; TUMOR PROTEIN;

CELLULAR DISTRIBUTION; CHROMOSOME 12; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FLP-IN-293 CELL LINE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; METAPHASE; MULTICOLOR FLUORESCENCE IN SITU HYBRIDIZATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; SECRETORY PATHWAY; STABLE EXPRESSION; TELOMERE; ANIMAL; ARTICLE; CELL LINE; GENE EXPRESSION; GENE TARGETING; GENETICS; IMMUNOBLOTTING; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; REPRODUCIBILITY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CELL LINE; DNA NUCLEOTIDYLTRANSFERASES; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE TARGETING; HUMANS; IMMUNOBLOTTING; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MUTATION; NEOPLASM PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 79952016115     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-756-3_9     Document Type: Chapter

References (48)

1. Ellgaard L, Molinari M, Helenius A (1999) Setting the standards: quality control in the secretory pathway. Science 286:1882–1888
2. Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181:223–230
3. Tu BP, Weissman JS (2004) Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 164:341–346
4. Sargsyan E, Baryshev M, Szekely L, Sharipo A, Mkrtchian S (2002) Identification of ERp29, an endoplasmic reticulum lumenal protein, as a new member of the thyroglobu-lin folding complex. J Biol Chem 277: 17009–17015
5. Knoblach B, Keller BO, Groenendyk J, Aldred S, Zheng J, Lemire BD, Li L, Michalak M (2003) ERp19 and ERp46, new members of the thioredoxin family of endoplasmic reticulum proteins. Mol Cell Proteomics 2:1104–1119
6. Helenius A, Aebi M (2004) Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73:1019–1049
7. Mori K (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101:451–454
8. Ellgaard L, Helenius A (2001) ER quality control: towards an understanding at the molecular level. Curr Opin Cell Biol 13: 431–437
9. Hampton RY (2002) ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 14:476–482
10. Kleizen B, Braakman I (2004) Protein folding and quality control in the endoplasmic reticulum. Curr Opin Cell Biol 16:343–349
11. Nakatsukasa K, Huyer G, Michaelis S, Brodsky JL (2008) Dissecting the ER-associated degradation of a misfolded polytopic membrane protein. Cell 132:101–112
12. Klein I, Sarkadi B, Varadi A (1999) An inventory of the human ABC proteins. Biochim Biophys Acta 1461:237–262
13. Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M, Bates SE (2009) ABCG2: a perspective. Adv Drug Deliv Rev 61:3–13
14. Vlaming ML, Lagas JS, Schinkel AH (2009) Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61: 14–25
15. Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsuruo T, Sugimoto Y (2002) Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer 97: 626–630
16. Mitomo H, Kato R, Ito A, Kasamatsu S, Ikegami Y, Kii I, Kudo A, Kobatake E, Sumino Y, Ishikawa T (2003) A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport. Biochem J 373: 767–774
17. Kage K, Fujita T, Sugimoto Y (2005) Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ ABCG2. Cancer Sci 96:866–872
18. Henriksen U, Fog JU, Litman T, Gether U (2005) Identification of intra-and intermo-lecular disulfide bridges in the multidrug resistance transporter ABCG2. J Biol Chem 280:36926–36934
19. Wakabayashi K, Nakagawa H, Adachi T, Kii I, Kobatake E, Kudo A, Ishikawa T (2006) Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system. J Exp Ther Oncol 5:205–222
20. Wakabayashi K, Nakagawa H, Tamura A, Koshiba S, Hoshijima K, Komada M, Ishikawa T (2007) Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein. J Biol Chem 282:27841–27846
21. Nakagawa H, Wakabayashi-Nakao K, Tamura A, Toyoda Y, Koshiba S, Ishikawa T (2009) Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of human ATP-binding cassette transporter ABCG2. FEBS J. 276:7237–7252
22. Tamura A, Wakabayashi K, Onishi Y, Nakagawa H, Tsuji M, Matsuda Y, Ishikawa T (2006) Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system. J Exp Ther Oncol 6:1–11
23. Tamura A, Wakabayashi K, Onishi Y, Takeda M, Ikegami Y, Sawada S, Tsuji M, Matsuda Y, Ishikawa T (2007) Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2. Cancer Sci 98:231–239
24. Nakagawa H, Tamura A, Wakabayashi K, Hoshijima K, Komada M, Yoshida T, Kometani S, Matsubara T, Mikuriya K, Ishikawa T (2008) Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. Biochem J 411:623–631
25. Furukawa T, Wakabayashi K, Tamura A, Nakagawa H, Morishima Y, Osawa Y, Ishikawa T (2009) Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations. Pharm Res 26:469–479
26. Wakabayashi K, Tamura A, Saito H, Onishi Y, Ishikawa T (2006) Human ABC transporter ABCG2 in xenobiotic protection and redox biology. Drug Metab Rev 38:371–391
27. Wakabayashi-Nakao K, Tamura A, Furukawa T, Nakagawa H, Ishikawa T (2009) Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation. Adv Drug Deliv Rev 61:66–72
28. O’Gorman S, Fox DT, Wahl GM (1991) Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251:1351–1355
29. Sauer B (1994) Site-specific recombination: developments and applications. Curr Opin Biotechnol 5:521–527
30. Aladjem MI, Brody LL, O’Gorman S, Wahl GM (1997) Positive selection of FLP- mediated unequal sister chromatid exchange products in mammalian cells. Mol Cell Biol 17:857–861
31. Morschhauser J, Michel S, Staib P (1999) Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination. Mol Microbiol 32:547–556
32. Nakano M, Odaka K, Ishimura M, Kondo S, Tachikawa N, Chiba J, Kanegae Y, Saito I (2001) Efficient gene activation in cultured mammalian cells mediated by FLP recombi-nase-expressing recombinant adenovirus. Nucleic Acids Res 29:E40
33. Voziyanov Y, Konieczka JH, Stewart AF, Jayaram M (2003) Stepwise manipulation of DNA specificity in Flp recombinase: progressively adapting Flp to individual and combinatorial mutations in its target site. J Mol Biol 326:65–76
34. Wirth D, Hauser H (2004) Flp-mediated integration of expression cassettes into FRT-tagged chromosomal loci in mammalian cells. Methods Mol Biol 267:467–476
35. Gronostajski RM, Sadowski PD (1985) Determination of DNA sequences essential for FLP-mediated recombination by a novel method. J Biol Chem 260:12320–12327
36. Jayaram M (1985) Two-micrometer circle site-specific recombination: the minimal substrate and the possible role of flanking sequences. Proc Natl Acad Sci U S A 82:5875–5879
37. Senecoff JF, Bruckner RC, Cox MM (1985) The FLP recombinase of the yeast 2-micron plasmid: characterization of its recombination site. Proc Natl Acad Sci U S A 82: 7270–7274
38. Andrews BJ, Proteau GA, Beatty LG, Sadowski PD (1985) The FLP recombinase of the 2 micron circle DNA of yeast: interaction with its target sequences. Cell 40:795–803
39. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530
40. Nelson JA, Reynolds-Kohler C, Smith BA (1987) Negative and positive regulation by a short segment in the 5’-flanking region of the human cytomegalovirus major immediate-early gene. Mol Cell Biol 7:4125–4129
41. Andersson S, Davis DL, Dahlback H, Jornvall H, Russell DW (1989) Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 264:8222–8229
42. Gritz L, Davies J (1983) Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25: 179–188
43. Broach JR, Hicks JB (1980) Replication and recombination functions associated with the yeast plasmid, 2 mu circle. Cell 21:501–508
44. Broach JR, Guarascio VR, Jayaram M (1982) Recombination within the yeast plasmid 2mu circle is site-specific. Cell 29:227–234
45. Argos P, Landy A, Abremski K, Egan JB, Haggard-Ljungquist E, Hoess RH, Kahn ML, Kalionis B, Narayana SV, Pierson LS 3rd, Sternberg N, Leong JM (1986) The integrase family of site-specific recombinases: regional similarities and global diversity. EMBO J 5:433–440
46. Craig NL (1988) The mechanism of conservative site-specific recombination. Annu Rev Genet 22: 77–105
47. Buchholz F, Ringrose L, Angrand PO, Rossi F, Stewart AF (1996) Different thermostabili-ties of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res 24:4256–4262
48. Mizuarai S, Aozasa N, Kotani H (2004) Single nucleotide polymorphisms results in impaired membrane localization and reduced ATPase activity in multidrug transporter ABCG2. Int J Cancer 109:238–246